⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

VRTX

Vertex Pharmaceuticals Incorporated

Healthcare · Biotechnology

523.93USD

-11.2400 (-2.10%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on VRTX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 523.93
P/E30.1
Dvd Ind Yld0.0%
P/B6.55
P/S10.5
Curr EV/T12M EBITDA25.4
Mkt Cap (USD)132.7B
Curr EV (USD)126.9B
2)

Per Share Data

EPS T12M17.15
DPS—
Bk Val Per Sh79.92
Rev/Sh49.32
Cash/Sh30.98
Curr Shares Out253.3M
FCF/Sh14.88
3)

Cash Flow Analysis

P/CF30.9
Curr P/FCF35.0
CF/NI1.0
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales34.1%
Eff Interest Rate0.7%
4)

Growth Potential

Dil EPS 1Y Gr836.5%
Cap 1Y Gr13.7%
BPS 1Y Gr13.7%
R&D To Sales25.4%
Retention Rate100.0%
Rev 1Y Gr8.9%
FCF 1Y Gr504.1%
Assets 1Y Gr13.8%
5)

Profitability

EBITDA5.0B
EBIT4.8B
Operating Margin38.0%
Pretax Margin41.9%
Net Margin35.0%
ROA17.1%
ROE23.5%
ROC18.0%
Asset Turnover0.49
6)

Structure

Current Ratio3.19
Quick Ratio2.54
Debt/Assets7.2%
Debt/Com Eq9.8%
Net Debt/EBITDA-0.83
Tot Debt/Capital8.9%
Gross Margin86.0%
EBIT/Int Exp359.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.